Drug Discovery

Robot holds up a pill
#AI #AI / data analytics / healthtech / informatics #Drug discovery #Generative AI

From knowledge to creation: keeping up with AI 

Generative AI is now rapidly disrupting entire industries and new technology breakthroughs are emerging at pace. As new iterations push the boundaries of deep research and insight generation, the implications for life sciences are both profound and uncertain. Reflecting on the rapid progression of GenAI, and its potential to… Read More

#Exclusive Content

Cancer research lab
#Cancer research #Drug development #Drug discovery #Oncology

UK immigration system is a barrier to cancer research, says CRUK 

A new report from Cancer Research UK (CRUK) indicates that the UK immigration system is having a detrimental effect on research in the UK.  CRUK’s institutes are led by and made up of a combination of UK and international researchers, but now it says that the UK… Read More

#News

#Clinical trials #Drug discovery #Funding #Immunology / Virology & Vaccines #Obesity

This week in drug discovery 1-5 September

News round-up for 1-5 September by DDW Editor Reece Armstrong. There have been a number of stories this week promoting promising science in the areas of obesity and cardiology, along with a partnership to advance vaccine science. The top stories Research programme represents a “new frontier in vaccine… Read More

#News

#Advanced Therapies #Drug discovery #Multiomics

White Paper – Accelerating Pharma Innovation and Drug Discovery with 5D Multiomics

Today’s drug discovery teams face increasing pressure to accelerate timelines, improve translational success, and minimise costly clinical failures. Yet most platforms still rely on fragmented technologies that deliver partial or delayed insights—forcing you to reconstruct biology from disconnected data. AVITI24™ 5D multiomics platform offers a new path by capturing RNA,… Read More

#Whitepapers

Vaccine
#Clinical trials #Drug discovery #Infectious diseases #Vaccines

Research programme represents a “new frontier in vaccine science” 

The UK’s University of Oxford, through its strategic partnership with the Ellison Institute of Technology (EIT), has received research funding of £118 ($159.7) million to launch an ambitious new programme of vaccine research.  Led by the Oxford Vaccine Group, the new initiative based in the University –… Read More

#Business & Investment #News

Eye health ophthalmology
#Clinical trials #Drug discovery #Gene therapy #Ophthalmology

Advancing gene-agnostic therapies for inherited retinal diseases 

DDW’s Megan Thomas speaks with Dr Arun Upadhyay, Chief Scientific Officer, Head of Research & Development at Ocugen, about the development of gene-agnostic modifier therapies for inherited retinal diseases, highlighting pathway discovery, preclinical models, dosing strategies, biomarker integration, and the potential expansion of this approach beyond ophthalmology. … Read More

#Exclusive Content #News

#Drug discovery #Flow Cytometry

Advance your flow cytometry research with spectral flow protocols

This handbook provides practical insights and application data to serve as a truly helpful guide for adapting to spectral flow cytometry—an advanced technology that elevates flow cytometry to the next level. In this handbook, you’ll find: Step-by-step protocols tailored for spectral flow cytometry Real-world application examples to guide your experiments… Read More

#Resources

#Drug discovery

App Notes – Get the scoop on Fluorescent Western Blotting

Looking to transition to fluorescent western blotting or wanting to maximise the output of your multiplex western blotting experiment? These two app notes cover all the essentials and more:  Best practices Troubleshooting tips  Easy to follow protocols Brought to you by    Copyright 2025 Drug Discovery World. Read More

#App Notes

#Ajna Biosciences #Botanical #Drug development #Plant-based #Therapeutics

New podcast: Redefining the future with plant-based therapeutics

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Joel Stanley, CEO… Read More

#News

Red blood cells
#Cardiovascular disease #Clinical trials #Drug development

Baxdrostat offers hope for stubborn high blood pressure 

A new treatment has been shown to significantly lower blood pressure in people whose levels stay dangerously high despite medication, according to the results of a Phase III clinical trial.  The international BaxHTN trial, led by Professor Bryan Williams, UCL Institute of Cardiovascular Science, and sponsored by… Read More

#News

Molecules
#AI #AI / data analytics / healthtech / informatics #Compounds #Drug discovery #Library screening

The evolution of chemical collections and drug-like diversity 

Andrea Altieri, Chief Scientific Officer, and Diana Zelencova-Gopejenko, Chief Executive Officer, Molport, explore how curated compound libraries—and the platforms that support them—are transforming the landscape of modern screening campaigns in drug discovery.  The development of screening libraries has closely followed advances in medicinal chemistry,… Read More

#Exclusive Content

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: Evaluate billions of compounds in record time

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Clinical trials #Drug discovery #National Institute for Health Research #UK

New network to boost industry clinical trials in the UK

The National Institute for Health and Care Research (NIHR) has awarded £6.5 (£8.7) million, funded jointly through a public-private partnership with the pharmaceutical industry, to establish a UK-wide Commercial Research Delivery Centre (CRDC) Network.   The new Network will provide strategic coordination of all 21 CRDCs across the… Read More

#News

#Drug discovery #European Medicines Agency #FDA #Health Canada #Regulatory

This week in drug discovery (25-29 August) 

News round-up for 25-29 August by DDW Senior Digital Content Editor Diana Turner. There have been some significant regulatory decisions this week, including a new orphan designation from the EMA and the FDA go-ahead for Rocket Pharma’s paused gene therapy trial. The top stories:… Read More

#News

#Drug discovery

Handbook – Advance your flow cytometry research with spectral flow protocols

This handbook provides practical insights and application data to serve as a truly helpful guide for adapting to spectral flow cytometry—an advanced technology that elevates flow cytometry to the next level.  In this handbook, you’ll find: Step-by-step protocols tailored for spectral flow cytometry Real-world application examples to guide your experiments… Read More

#Guides